London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
www.hulldailymail.co.uk/news/business/croda-strike-missing-holiday-pay-4752030.amp
Can anyone assist with whats the +/- of the options and suggestions?
Thanks
rocker1
Thanks for heads up on ITX. After a decent amount of personal research I opened up a small position
Interim dividend held at 39.5 pence, it seems that although Covid-19 has had some effect on half year result it is not that substantial.
Our new Cryptocurrency section has arrived! Click here
Share PricesItaconix Plc Share PriceItaconix Plc Regulatory NewsFirst order to Croda for new odour control polymer
Itaconix Plc Regulatory News (ITX)
ITX Share
Price
ITX Share
News
ITX Share
Chat
10
ITX Share
Trades
14
ITX
Live RNS
1
ITX Information Buy ITX SharesAdd ITX to WatchlistAdd ITX to AlertAdd ITX to myTerminal
Share Price
First order to Croda for new odour control polymer
Tue, 7th Jan 2020 07:00
RNS Number : 9161Y
Itaconix PLC
07 January 2020
7 January 2020
Itaconix plc ("Itaconix" or "the Company")
Itaconix delivers first order of new sustainable odour control polymer to Croda
Itaconix (LSE: ITX) (OTCQB: ITXXF), a leading innovator in sustainable specialty polymers, is pleased to announce the delivery of the first order of ZINADOR™ 35L to Croda.
The Company announced in October 2019 an expansion of its global supply agreement in odour control products with Croda to include both ZINADOR™ 22L and 35L. The new ZINADOR™ 35L is a more concentrated version of Itaconix's proprietary polymeric complex that delivers performance and cost advantages in detergent and industrial applications.
John R. Shaw, CEO of Itaconix, stated: "The launch of ZINADOR™ 35L through our collaboration with Croda is a significant commercial milestone for us. I believe the performance and cost advantages available with ZINADOR™ 35L can generate new and broader use of our odour control polymers."
Brilliant company held on to these and invested a set amount on a monthly basis. Excellent return also bought a company called ITX small company which croda has recently done a deal with. Share price only 1.62p huge potential for a risk taker huge returns in a small amount of time. The charts turning after years of declines . Get in at the bottom. Polymer product that croda seem interested in. They could even take them out as the market cap is peanuts.
Very nice! Will be reinvested back into the company to continue growing!
From 510 to 5100 in 10 years! What a company. Look at the graph, slow and steady growth. No big jumps, no big dips, just a relentless path of growth. If you could give me a handful of the companies I'd retire tomorrow.
Having worked at Croda for 5 years based at Cowick Hall, I can't express what an exceptionally run company this is. They have products in so many markets that the company is so resilient to market instability factors. They've acquired some of the most innovative growing companies. The main one they got when I was there was an Italian based stem cell company. One of the things we used to say on the company profile was that 90% of the products you see will contain a croda product in them in some shape or form. They have some of the best experts in hair and skin care and equally strong sales and marketing force worldwide. I've never known a company to post such impressive growth percentages. The key thing with Croda is that they wanted to focus on high end products which they had the pricing power rather than bog standard commodities which would have been under severe pricing pressures.
My first buy of Croda was at £5.34 in January 2009, I sold at £8.93 13 months later, since then I have bought and then sold Croda at a modest profit on three occasions. Had I stuck to my original Croda holding in the last 9 years my investment would have appreciated ten fold. Just illustrates that ducking in and out of a share does not pay off.
My latest Croda buy was at just under £45, I don't intend to sell again.
In the case of Croda I forgot Warren Buffett's advice "When you find good stocks, buy them at low prices and hold them."
used to be £7 a share few years ago , i should have stick with it.
Wow £50 what a share to be in. :)))
Do I pay Stamp Duty on these shares? Thanks.
Not sure it looks low enough even after today's fall to justify an investment.
Should have spotted this earlier "June 18 2014 Sean Christie to step down as Group Finance Director in April 2015 Croda International Plc ('Croda' or 'the company') today announces that Sean Christie, Group Finance Director, will stand down following eight highly successful years with the company. To allow time for his replacement to be found and an orderly transition, Sean will remain Group Finance Director and on the Board until April 2015. " Seems like the CEO spotted the fault and has moved already. I hope they hurry up and get something in place
It worries me when a strong company uses this excuse. Basically they hire a CFO or they hire a dumb one. Currency movements happen all the time so they needed a plan and by the sounds of it got it wrong. Makes me want to tear my hair out.
Croda International: Barclays increases target price from 2260p to 2360p and maintains an equal-weight rating.
Croda International: Credit Suisse ups target price from 2100p to 2500p and maintains a neutral rating.
Croda International: Morgan Stanley moves target price from 2430p to 2700p and reiterates an overweight rating.
Croda International: Berenberg ups target price from 2600p to 2700p, while its buy recommendation is retained.
Croda International: Jefferies initiates with a target price of 2300p and a hold recommendation.
Croda International: Bank of America ups target price from 2350p to 2500p staying with its buy recommendation.
Canaccord Genuity has stuck with its "sell" stance on chemicals company Croda International (CRDA) with a target price of 1,900p, despite many of its competitors opting to upgrade their own recommendations. The broker feels that although the firm is better positioned than others in the sector, its portfolio is more sensitive to cyclical slowdowns then the market had expected. The broker is also cautious of the fact that growth in operating profits has slowed to less than 10% in the last two quarters as opposed to 2006-2011, where growth was over 30%. Shares in the company inched up by 1p to 2,278p.
Goldman Sachs has reiterated a 'buy' recommendation on Croda International, reducing its price target to 3150p from 3340p. This still provides over 45% upside on its current price of approximately 2160p. Following slightly disappointing third quarter results from the specialty chemicals company, Goldman analysts have lowered their earnings per share (EPS) forecasts for 2012-14 by 4% with nearly half of the reduction being a result of foreign exchange movements. However, they believe "Croda is exposed to some of the strongest structural growth themes (e.g consumer care) within the sector". As a consequence they state: "We would view any weakness as an opportunity to buy a 2020 Vision Leader at a depressed valuation. Croda trades at 8.6 times 2014 estimates of EV/EBITDA [enterprise value/earnings before interest, tax, depreciation and amortisation] verses a historical average of 9.5 times, despite stronger returns relative to history." Goldman Sachs' twelve-month price target moves to 3150p (from 3340p) and is based on 11.5 times 2014 estimates of EV/EBITDA.